INFLAMMATIX
Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system. It is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. They are initially focused on developing tests for acute bacterial and viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University. The company was founded by Timothy Sweeney and Jonathan Romanowsky in California.
INFLAMMATIX
Industry:
Big Data Bioinformatics Biotechnology Health Care Health Diagnostics
Founded:
2016-01-01
Address:
Burlingame, California, United States
Country:
United States
Website Url:
http://www.inflammatix.com
Total Employee:
51+
Status:
Active
Contact:
650-443-3030
Email Addresses:
[email protected]
Total Funding:
137.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
CareDx
CareDx is a novel molÂeÂcÂuÂlar diagnosÂtics comÂpany.
Current Advisors List
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Inflammatix
OSF Ventures
OSF Ventures investment in Series D - Inflammatix
D1 Capital Partners
D1 Capital Partners investment in Series D - Inflammatix
Think.Health
Think.Health investment in Series D - Inflammatix
Northpond Ventures
Northpond Ventures investment in Series D - Inflammatix
Khosla Ventures
Khosla Ventures investment in Series D - Inflammatix
DARPA
DARPA investment in Grant - Inflammatix
Northpond Ventures
Northpond Ventures investment in Series C - Inflammatix
Grey Sky Venture Partners
Grey Sky Venture Partners investment in Series C - Inflammatix
Khosla Ventures
Khosla Ventures investment in Series C - Inflammatix
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-15 | Inflammatix Appoints Purvesh Khatri as Chief Scientific Officer |
| 2021-04-15 | Inflammatix Appoints Amy Boyle as Chief Operating Officer |
Official Site Inspections
http://www.inflammatix.com Semrush global rank: 4.62 M Semrush visits lastest month: 2.17 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Inflammatix"
Inflammatix - Crunchbase Company Profile & Funding
Inflammatix develops novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system. It is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical …See details»
Inflammatix - The Org
Inflammatix, Inc. is a venture-backed startup located in the San Francisco Bay Area that is building novel diagnostics for acute infections and sepsis based on unique immune …See details»
Inflammatix 2025 Company Profile: Valuation, Funding …
Inflammatix General Information Description. Developer of molecular diagnostics tests designed to resolve clinical and public health challenges. The company's …See details»
Inflammatix Names Martín Vazquez as Chief Operating Officer to …
3 days ago Inflammatix, a leader in AI-powered immune response diagnostics, today announced the appointment of Martín Vazquez as chief operating officer (COO). The hire marks a major …See details»
Inflammatix Company Profile - Craft
Inflammatix has 5 employees across 2 locations and $33 m in total funding,. See insights on Inflammatix including office locations, competitors, revenue, financials, executives, …See details»
Inflammatix, Inc - VentureRadar
Similar Companies: FiNDeR India Research Institute Foundation for Neglected Disease Research (FNDR) is a unique not for profit R&D organization dedicated to developing novel therapeutics, …See details»
Inflammatix - Work in biotech
Inflammatix is developing immune response diagnostics to identify the presence of bacterial and viral infections. Biomarkers in blood can reveal if a patient is mounting an immune response to …See details»
Inflammatix | Interpreting the immune response to …
Inflammatix host response diagnostics are powered by ‘reading’ the immune system. Our immune system has developed targeted responses to different types of infections and other diseases over millions of years of evolution. Leveraging …See details»
Inflammatix - rawventures.com
Inflammatix is a cutting-edge biotechnology firm that is disrupting healthcare by creating a point-of-care, precision medicine solution that, by reading a body’s immune response, can help …See details»
Inflammatix - Contacts, Employees, Board Members, Advisors
Organization. Inflammatix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Profiles 3. Contacts 76. About. Inflammatix has 9 …See details»
Inflammatix collects $57M as it awaits FDA review of infectious …
Sep 12, 2024 Inflammatix previously raised $102 million in its 2021 series D financing, aimed at supporting its clinical development programs. The company’s pipeline also includes a separate …See details»
Inflammatix - Leadership Team - The Org
The Leadership Team at Inflammatix is responsible for guiding the strategic direction of the company, driving innovation in diagnostic solutions for acute infections and sepsis, and …See details»
Inflammatix Names Martín Vazquez as Chief Operating Officer to …
4 days ago Seasoned medtech executive joins as hospital adoption accelerates for breakthrough diagnostic in acute infection and sepsis care. Sunnyvale, Calif., June 10, 2025 …See details»
Inflammatix, Inc. SINCE ITS FOUNDING IN Advanced Single Point …
The Inflammatix HostDx-Sepsis test can rapidly identify the presence of bacterial or viral infections (including COVID-19) in less than 30 minutes, getting the right therapy to patients …See details»
Inflammatix | news, press, blogs, podcasts
Sep 12, 2024 Inflammatix Presents Data at ACEP24 Showing High Diagnostic and Prognostic Accuracy of its TriVerityâ„¢ Test Regardless of Patient Immune Status September 12, 2024 …See details»
Inflammatix Gets FDA Clearance for 30-Minute Sepsis Test, Preps …
Jan 21, 2025 Inflammatix was cofounded in 2016 as a Stanford University spinout, and the work to develop the TriVerity test began with a project to understand critical illness through mRNA …See details»
Login - Inflammatix
Username or E-mail. Password. Remember MeSee details»
News - Inflammatix
Sep 12, 2024 Inflammatix begins trial evaluating mRNA test for patient infection status. November 12, 2024. Inflammatix Adds MedTech Veteran as First General Counsel. October …See details»
Press releases - Inflammatix
Nov 28, 2023 Inflammatix Names Martín Vazquez as Chief Operating Officer to Drive National Scale-Up of TriVerityâ„¢ Test System. March 25, 2025. Inflammatix Ships TriVerityâ„¢ Test …See details»
Inflammatix | Groundbreaking tests to address unmet needs
Inflammatix has been at the forefront of sepsis subtypes (or ‘endotypes’) research in transcriptomics, with a classifier that has been validated 3, 4 in research settings to produce …See details»